CY1112256T1 - Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της - Google Patents

Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της

Info

Publication number
CY1112256T1
CY1112256T1 CY20121100069T CY121100069T CY1112256T1 CY 1112256 T1 CY1112256 T1 CY 1112256T1 CY 20121100069 T CY20121100069 T CY 20121100069T CY 121100069 T CY121100069 T CY 121100069T CY 1112256 T1 CY1112256 T1 CY 1112256T1
Authority
CY
Cyprus
Prior art keywords
preparation
pharmaceutical dosage
forming containers
dosage forming
containers
Prior art date
Application number
CY20121100069T
Other languages
English (en)
Inventor
Isabel Anstett-Klein
Marc Schiller
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of CY1112256T1 publication Critical patent/CY1112256T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μέθοδος παρασκευής για παραγωγή δοσολογικών μορφών για χορήγηση από το στόμα δραστικών συστατικών περιγράφεται.
CY20121100069T 2004-05-07 2012-01-19 Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της CY1112256T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101982 2004-05-07
EP05743110A EP1746980B1 (en) 2004-05-07 2005-05-04 Pharmaceutical dosage form comprising pellets as well as its manufacturing process

Publications (1)

Publication Number Publication Date
CY1112256T1 true CY1112256T1 (el) 2015-12-09

Family

ID=34929072

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100069T CY1112256T1 (el) 2004-05-07 2012-01-19 Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της

Country Status (15)

Country Link
US (1) US20070231388A1 (el)
EP (1) EP1746980B1 (el)
JP (1) JP2007536349A (el)
AT (1) ATE531361T1 (el)
AU (1) AU2005239838B2 (el)
CA (1) CA2565083C (el)
CY (1) CY1112256T1 (el)
DK (1) DK1746980T3 (el)
ES (1) ES2376466T3 (el)
HR (1) HRP20120049T1 (el)
PL (1) PL1746980T3 (el)
PT (1) PT1746980E (el)
RS (1) RS52233B (el)
SI (1) SI1746980T1 (el)
WO (1) WO2005107721A2 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
ES2400964T3 (es) 2007-04-04 2013-04-15 Sigmoid Pharma Limited Composiciones famacéuticas de ciclosporina
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
CN103442727B (zh) 2011-02-11 2016-08-10 Zx制药有限责任公司 多微粒l-薄荷醇制剂及相关方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
RS58325B1 (sr) * 2013-04-23 2019-03-29 Zx Pharma Llc Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
ES2858517T3 (es) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina
CN104382881A (zh) * 2014-11-20 2015-03-04 哈尔滨圣吉药业股份有限公司 一种甲砜霉素肠溶微丸及其制备方法
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7212484B2 (ja) * 2017-09-20 2023-01-25 大原薬品工業株式会社 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
ES2032394T3 (es) * 1986-02-20 1993-02-16 Hoechst Aktiengesellschaft Procedimiento para preparar derivados de tienoimidazol sustituidos.
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
CA1256109A (en) * 1986-09-10 1989-06-20 Franz Rovenszky Process for the preparation of derivatives of 4, 5-dihydrooxazoles
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
IL85472A (en) 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3901151A1 (de) 1989-01-17 1990-07-19 Hoechst Ag Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
DE4322572A1 (de) 1993-07-07 1995-01-12 Byk Gulden Lomberg Chem Fab Beutelverpackung für flüssige Arzneimittel
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
DK173431B1 (da) 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
ES2244167T3 (es) * 1999-12-16 2005-12-01 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos.
US6346269B1 (en) 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo

Also Published As

Publication number Publication date
RS52233B (en) 2012-10-31
SI1746980T1 (sl) 2012-03-30
WO2005107721A2 (en) 2005-11-17
CA2565083C (en) 2014-07-08
DK1746980T3 (da) 2012-01-30
PT1746980E (pt) 2012-01-25
AU2005239838A1 (en) 2005-11-17
ES2376466T3 (es) 2012-03-14
CA2565083A1 (en) 2005-11-17
ATE531361T1 (de) 2011-11-15
EP1746980A2 (en) 2007-01-31
PL1746980T3 (pl) 2012-03-30
HRP20120049T1 (hr) 2012-02-29
EP1746980B1 (en) 2011-11-02
AU2005239838B2 (en) 2011-08-11
WO2005107721A3 (en) 2006-07-20
US20070231388A1 (en) 2007-10-04
JP2007536349A (ja) 2007-12-13

Similar Documents

Publication Publication Date Title
CY1112256T1 (el) Φαρμακευτικη δοσολογικη μορφη που περιεχει σφαιριδια καθως και μεθοδος παρασκευης της
DE60321351D1 (de) Verfahren zur herstellung von oral verzehrbaren darreichungsformen
EP1893182B8 (en) Oral dosage forms comprising progesterone and method of making and using the same
NO20043723L (no) Farmasoytisk doseringform for avgivese gjennom slimhinner
WO2005097076A3 (en) Low dose pharmaceutical products
IL179719A0 (en) Process for preparation of amorphous form of drug
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
HUP0303800A2 (hu) Gyógyszerkészítmények, adagolási formák epotilonok orális beadására
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
ATE454132T1 (de) Rasch in der mundhöhle schmelzende tablette
HUP0302874A2 (hu) Eljárás risperidon előállítására
MY146988A (en) Fexofenadine suspension formulation
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
ATE401075T1 (de) Cytisinehaltiges arzneimittel
JP2005525329A5 (el)
ATE380545T1 (de) Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung
DE50211212D1 (de) Pharmazeutische zubereitung enthaltend wirkstoffe aus den pflanzen centella asiatica, mahonia aquifolium und viola tricolor
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
ATE344665T1 (de) Verfahren zur herstellung einer einen antiretroviralen proteasehemmer enthaltenden pharmazeutischen zusammensetzung mit verbesserter bioverfügbarkeit
ECSP045048A (es) Nueva forma sólida de dosificación oral de 5- [2-etoxi- 5(4-metilpiperazin-1-il sulfonil) fenil] -1,6-dihidro-1-metil-3-propilpirazolo [4,3-d] pirimidin-7-ona citrato y proceso para su fabricación
TH84855B (th) การใช้สารผสมเซเลคอกซิบสำหรับบรรเทาอาการปวดอย่างรวดเร็ว
AR034701A1 (es) Nuevas composiciones farmaceuticas con accion antidiabetica y proceso para su preparacion
TH80954A (th) สารผสมและวิธีการสำหรับการบำบัดโรคหอบหืด